Placenta growth factor expression in human atherosclerotic carotid plaques is related to plaque destabilization

Atherosclerosis

Volumn 196, Issue 1, 2008, Pages 333-340

  Pilarczyk, Kevin ^a   Sattler, Katherine J E ^a   Galili, Offer ^a   Versari, Daniele ^a   Olson, Monica L ^a   Meyer, Frederic B ^a   Zhu, Xiang Yang ^a   Lerman, Lilach O ^a   Lerman, Amir ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

Atherosclerosis; Carotid arteries; Inflammation; Placenta growth factor; Vascularization

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; PLACENTAL GROWTH FACTOR;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL INFILTRATION; CONTROLLED STUDY; DENSITOMETRY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULARIZATION; WESTERN BLOTTING;

AGED; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID STENOSIS; CASE-CONTROL STUDIES; COHORT STUDIES; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NEOVASCULARIZATION, PATHOLOGIC; PREGNANCY PROTEINS;

EID: 38049068685     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.10.038     Document Type: Article

References (43)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Carr S., Farb A., Pearce W.H., Virmani R., and Yao J.S. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg 23 (1996) 755-765
3. Fleiner M., Kummer M., Mirlacher M., et al. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation 110 (2004) 2843-2850
4. Moreno P.R., Purushothaman K.R., Fuster V., et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 110 (2004) 2032-2038
5. Mofidi R., Crotty T.B., McCarthy P., et al. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. Br J Surg 88 (2001) 945-950
6. Loftus I.M., Naylor A.R., Goodall S., et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 31 (2000) 40-47
7. Shah P.K., Falk E., Badimon J.J., et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 92 (1995) 1565-1569
8. Lutgens E., and Daemen M.J. CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc Med 12 (2002) 27-32
9. Yeh E.T. CRP as a mediator of disease. Circulation 109 (2004) II 11-II 14
10. Verma S., Devaraj S., and Jialal I. Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation 113 (2006) 2135-2150
11. Venugopal S.K., Devaraj S., Yuhanna I., Shaul P., and Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 106 (2002) 1439-1441
12. Lin R., Liu J., Gan W., and Yang G. C-reactive protein-induced expression of CD40-CD40L and the effect of lovastatin and fenofibrate on it in human vascular endothelial cells. Biol Pharm Bull 27 (2004) 1537-1543
13. Schonbeck U., Mach F., and Libby P. CD154 (CD40 ligand). Int J Biochem Cell Biol 32 (2000) 687-693
14. Mach F., Schonbeck U., Sukhova G.K., Atkinson E., and Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394 (1998) 200-203
15. Donnini S., Machein M.R., Plate K.H., and Weich H.A. Expression and localization of placenta growth factor and PlGF receptors in human meningiomas. J Pathol 189 (1999) 66-71
16. Matsumoto K., Suzuki K., Koike H., et al. Placental growth factor gene expression in human prostate cancer and benign prostate hyperplasia. Anticancer Res 23 (2003) 3767-3773
17. Perelman N., Selvaraj S.K., Batra S., et al. Placenta growth factor activates monocytes and correlates with sickle cell disease severity. Blood 102 (2003) 1506-1514
18. Carmeliet P., Moons L., Luttun A., et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7 (2001) 575-583
19. Sattler K.J., Woodrum J.E., Galili O., et al. Concurrent treatment with renin-angiotensin system blockers and acetylsalicylic acid reduces nuclear factor kappaB activation and C-reactive protein expression in human carotid artery plaques. Stroke 36 (2005) 14-20
20. Rodriguez-Porcel M., Lerman L.O., Holmes Jr. D.R., et al. Chronic antioxidant supplementation attenuates nuclear factor-kappa B activation and preserves endothelial function in hypercholesterolemic pigs. Cardiovasc Res 53 (2002) 1010-1018
21. Zhu X.Y., Rodriguez-Porcel M., Bentley M.D., et al. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 109 (2004) 2109-2115
22. Sawano A., Takahashi T., Yamaguchi S., Aonuma M., and Shibuya M. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ 7 (1996) 213-221
23. Neufeld G., Kessler O., and Herzog Y. The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF. Adv Exp Med Biol 515 (2002) 81-90
24. Clauss M., Weich H., Breier G., et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 271 (1996) 17629-17634
25. Clauss M. Functions of the VEGF receptor-1 (FLT-1) in the vasculature. Trends Cardiovasc Med 8 (1998) 241-245
26. Rohde L.E., and Lee R.T. Pathophysiology of atherosclerotic plaque development and rupture: an overview. Semin Vasc Med 3 (2003) 347-354
27. Sitzer M., Muller W., Siebler M., et al. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke 26 (1995) 1231-1233
28. Schonbeck U., Mach F., Sukhova G.K., et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?. Circ Res 81 (1997) 448-454
29. Mach F., Schonbeck U., Bonnefoy J.Y., Pober J.S., and Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96 (1997) 396-399
30. Khurana R., Moons L., Shafi S., et al. Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation. Circulation 111 (2005) 2828-2836
31. Luttun A., Tjwa M., Moons L., et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8 (2002) 831-840
32. Heeschen C., Dimmeler S., Fichtlscherer S., et al. CAPTURE Investigators. Prognostic value of placental growth factor in patients with acute chest pain. JAMA 291 (2004) 435-441
33. Bisoendial R.J., Kastelein J.J., Levels J.H., et al. Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res 96 (2005) 714-716
34. Verma S., Li S.H., Badiwala M.V., et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 105 (2002) 1890-1896
35. Torzewski M., Rist C., Mortensen R.F., et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 20 (2000) 2094-2099
36. Schonbeck U., and Libby P. CD40 signaling and plaque instability. Circ Res 89 (2001) 1092-1103
37. Kotowicz K., Dixon G.L., Klein N.J., Peters M.J., and Callard R.E. Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes. Immunology 100 (2000) 441-448
38. Slupsky J.R., Kalbas M., Willuweit A., et al. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost 80 (1998) 1008-1014
39. May A.E., Kalsch T., Massberg S., et al. Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation 106 (2002) 2111-2117
40. Larsson A., and Hansson L.O. High sensitivity CRP and serum amyloid A as expressions of low grade inflammation do not correlate with bFGF or VEGF. Ups J Med Sci 108 (2003) 51-59
41. Krupinski J., Turu M.M., Martinez-Gonzalez J., et al. Endogenous expression of C-reactive protein is increased in active (ulcerated noncomplicated) human carotid artery plaques. Stroke 37 (2006) 1200-1204
42. McCarthy M.J., Loftus I.M., Thompson M.M., et al. Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J Vasc Surg 30 (1999) 261-268
43. Costa C., Soares R., and Schmitt F. Angiogenesis: now and then. APMIS 112 (2004) 402-412